Diagnostic Test Analyses in Search of Their Gold Standard: Latent Class Analyses with Random Effects
Overview
Science
Affiliations
We review methods for analysing the performance of several diagnostic tests when patients must be classified as having a disease or not, when no gold standard is available. For latent class analysis (LCA) to provide consistent estimates of sensitivity, specificity and prevalence, traditionally 'independent errors conditional on disease status' have been assumed. Recent approaches derive estimators under more flexible assumptions. However, all likelihood-based approaches suffer from the sparseness of tables generated by this type of data; an issue which is often ignored. In light of this, we examine the potential and limitations of LCAs of diagnostic tests. We are guided by a data set of visceral leishmaniasis tests. In the example, LCA estimates suggest that the traditional reference test, parasitology, has poor sensitivity and underestimates prevalence. From a technical standpoint, including more test results in one analysis yields increasing degrees of sparseness in the table which are seen to lead to discordant values of asymptotically equivalent test statistics and eventually lack of convergence of the LCA algorithm. We suggest some strategies to cope with this.
Okkaoglu Y, Welton N, Jones H BMC Med Res Methodol. 2024; 24(1):299.
PMID: 39639189 PMC: 11619692. DOI: 10.1186/s12874-024-02432-x.
Neurocysticercosis Diagnosis in a Non-Endemic Country: France.
Zemmour I, Durieux M, Herault E, Rouges C, Soba B, Mercier A Pathogens. 2023; 12(10).
PMID: 37887721 PMC: 10610462. DOI: 10.3390/pathogens12101205.
Agarwal R, Saxena P, Muthu V, Sehgal I, Dhooria S, Prasad K Front Cell Infect Microbiol. 2022; 12:861866.
PMID: 35402294 PMC: 8990730. DOI: 10.3389/fcimb.2022.861866.
Evaluation of LAMP for detection of from stool samples in children.
Raghavan R, Wang S, Dendukuri N, Kar S, Mahadevan S, Jagadisan B Access Microbiol. 2020; 2(11):acmi000169.
PMID: 33294772 PMC: 7717480. DOI: 10.1099/acmi.0.000169.
Prevalence of SARS-CoV-2, Verona, Italy, April-May 2020.
Guerriero M, Bisoffi Z, Poli A, Micheletto C, Conti A, Pomari C Emerg Infect Dis. 2020; 27(1).
PMID: 33261716 PMC: 7774528. DOI: 10.3201/eid2701.202740.